Showing all 2 results
Hydrochlorothiazide Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (scored for titration). Accurate low-dose titration is critical for modern therapy.
Active Ingredient Strength (Standard) Role Hydrochlorothiazide USP/BP 12.5 mg Initial Dose / Combination Use Hydrochlorothiazide USP/BP 25 mg Standard Therapeutic Dose Hydrochlorothiazide USP/BP 50 mg Edema / High Potency Excipients Q.S. Lactose (Filler) / Starch Ramipril & Hydrochlorothiazide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet or Capsule, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly degradable Ramipril molecule.
Active Ingredient Strength Primary Clinical Function Ramipril Ph.Eur./USP 5 mg (or 2.5 mg / 10 mg) ACE inhibition for vasodilation, RAAS blockade, and critical potassium retention. Hydrochlorothiazide Ph.Eur./USP 12.5 mg / 25 mg Global Clinical Standard: Thiazide diuretic for sodium excretion and sustained blood volume reduction. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Sodium Bicarbonate / Hypromellose / Magnesium Stearate Diluent / Superdisintegrant / Alkaline Stabilizing Agent (Engineered specifically to protect Ramipril from acidic degradation and moisture-induced cyclization) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict, high-compliance 30-day chronic cardiology dispensing regimens).
